PMID: 8220890Sep 1, 1993Paper

A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig

British Journal of Pharmacology
M Rechtman, H Majewski


1. In pithed rats, preganglionic vagal nerve stimulation (at 5 Hz) elicited a bradycardia. This bradycardia was potentiated by the angiotensin converting enzyme inhibitor, captopril (1 mg kg-1, i.v.) by about 40%. Subsequent angiotensin II infusion (0.03 micrograms kg-1 min-1) reversed this effect. A similar facilitatory effect was also seen with the angiotensin receptor antagonist, losartan (10 mg kg-1, i.v.). These results suggest a tonic inhibitory effect of endogenous angiotensin II on vagal transmission. 2. The effect of captopril in potentiating vagal bradycardia appears to be at the level of vagal neurones, since the bradycardia elicited by the muscarinic agonist, methacholine was unaffected. 3. After the pithed rats were nephrectomized, captopril had no effect on vagally-induced bradycardia, suggesting that the formation of the endogenous angiotensin II responsible for the effect was dependent on renin release from the kidney. 4. When the sympathetic nerves of the pithed rat were electrically stimulated there was a tachycardia, and this was unaffected by captopril. However, when the sympathetic and vagus nerves were activated concurrently, the resulting tachycardia was inhibited by captopril. 5. In pithed guinea-pigs, c...Continue Reading


Jan 1, 1977·Reviews of Physiology, Biochemistry and Pharmacology·K Starke
Jan 1, 1976·Annual Review of Biochemistry·R L Soffer
Apr 11, 1991·American Journal of Hypertension·A T ChiuP B Timmermans
Apr 11, 1991·American Journal of Hypertension·P C WongP B Timmermans
Oct 1, 1989·Journal of Cardiovascular Pharmacology·H Majewski
Nov 30, 1989·Biochemical and Biophysical Research Communications·A T ChiuA L Johnson
Jan 20, 1989·JAMA : the Journal of the American Medical Association·L P BouletY Lacourcière
Dec 1, 1989·Clinical and Experimental Pharmacology & Physiology·M A MianM J Rand
Sep 1, 1985·British Journal of Clinical Pharmacology·J F GiudicelliD Jacolot
Mar 1, 1988·British Journal of Clinical Pharmacology·G B KondoweD W Harron
Jan 1, 1970·Naunyn-Schmiedebergs Archiv Für Pharmakologie·K Löffelholz, E Muscholl
Jan 1, 1982·Journal of Cardiovascular Pharmacology·R Hatton, D P Clough
Sep 1, 1984·Journal of Cardiovascular Pharmacology·H MajewskiK Starke
Dec 1, 1982·British Journal of Clinical Pharmacology·A SturaniP Zucchelli
Jan 1, 1981·Annual Review of Physiology·M N LevyS L Stuesse
Jan 1, 1982·British Journal of Pharmacology·E K Potter

❮ Previous
Next ❯


Jun 1, 1997·Progress in Neurobiology·H ZhuoC J Helke
Aug 1, 1997·Clinical and Experimental Pharmacology & Physiology·H MajewskiI F Musgrave
Jun 18, 2010·Canadian Journal of Physiology and Pharmacology·Anita MehtaRamesh Goyal
May 8, 2019·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Fumiko YamakiYoshio Tanaka
Jul 24, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Toru KawadaMasaru Sugimachi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.